RecoSMA® Enters Kuwait: First Clinical Implementation at Farwaniya Hospital
2025-09-18 14:21
A significant milestone has been reached in Kuwait.
RecoSMA® regenerative laser technology has been clinically introduced at Farwaniya Hospital, Diabetic Foot Department, under the leadership of Dr. Nasser Alhumaidi — marking the first application of this regenerative method in the country.
During two intensive clinical training days, the hospital team initiated a structured clinical program for the treatment of diabetic foot ulcers. This is not merely the installation of new equipment — it represents the beginning of a new therapeutic approach in Kuwaiti wound care.
RecoSMA® is a patented, non-thermal laser technology delivering ultra-short pulses precisely tuned to interact with tissue water. Instead of causing coagulative heat damage, it generates controlled micro-acoustic effects that:
Support angiogenesis
Stimulate extracellular matrix (ECM) remodeling
Promote anti-fibrotic biological responses
Activate regenerative pathways critical for chronic wound healing
These mechanisms are particularly relevant in ischemic and diabetic wounds, where conventional treatments often reach their limits.
We extend our sincere appreciation to Dr. Nasser Alhumaidi and his clinical team for their commitment to innovation and clinical advancement. Special thanks to our international trainer, Dr. Katarína Szabómihályová, for leading the hands-on sessions, and to Mr. Ghaith Saltaji together with Advanced Technology Company — LINLINE’s distributor in Kuwait — for their strategic support and dedication in bringing this project to life.
At LINLINE Medical Systems SIA, we believe progress in wound care requires more than incremental improvement. It requires a shift in therapeutic logic — from destructive intervention toward precise, regeneration-driven strategies.